Department For International Development
This study aims to determine the prevalence of resistance to rifampicin alone; rifampicin and isoniazid, and second-line anti-TB drugs among sputum smear-positive tuberculosis patients in Zimbabwe.
This research was supported by the UK Department for International Developments Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)
Timire C, Metcalfe JZ, Chirenda J, Scholten JN, Manyame-Murwira B, Ngwenya M, Matambo R, Charambira K, Mutunzi H, Kalisvaart N, Sandy C. Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey. International Journal of Infectious Diseases. 2019;87:11925.